0000000000287526

AUTHOR

F. Ferrari

showing 7 related works from this author

Consensus protocol for EEG and amplitude-integrated EEG assessment and monitoring in neonates

2021

The aim of this work is to establish inclusive guidelines on electroencephalography (EEG) applicable to all neonatal intensive care units (NICUs). Guidelines on ideal EEG monitoring for neonates are available, but there are significant barriers to their implementation in many centres around the world. These includebarriers due to limited resources regarding the availability of equipment and technical and interpretive round-the-clock personnel. On the other hand, despite its limitations, amplitude-integrated EEG (aEEG) (previously called Cerebral Function Monitor [CFM]) is a common alternative used in NICUs.The Italian Neonatal Seizure Collaborative Network (INNESCO), working with all nation…

medicine.medical_specialtyConsensusCollaborative networkSocio-culturaleConsensuReviewElectroencephalographyGuidelineClinical neurophysiology050105 experimental psychology03 medical and health sciences0302 clinical medicineSeizuresPhysiology (medical)Intensive careIntensive Care Units NeonatalHypoxic-ischemic encephalopathyMedicineHumans0501 psychology and cognitive sciencesNeonatal seizureProtocol (science)medicine.diagnostic_testbusiness.industryGuideline Review Electroencephalography Newborn Seizures Hypoxic-ischemic encephalopathy05 social sciencesElectroencephalography; Guideline; Hypoxic-ischemic encephalopathy; Newborn; Review; SeizuresInfant NewbornElectroencephalographyGuidelinemedicine.diseaseNewbornSeizureSensory SystemsSystematic reviewNeurologyItalyNeurology (clinical)Medical emergencybusiness030217 neurology & neurosurgeryHuman
researchProduct

First Observation of Top Quark Production in the Forward Region

2015

Top quark production in the forward region in proton-proton collisions is observed for the first time. The W + b final state with W → μν is reconstructed using muons with a transverse momentum, p[subscript T], larger than 25 GeV in the pseudorapidity range 2.0 20  GeV. The results are based on data corresponding to integrated luminosities of 1.0 and 2.0  fb[superscript -1] collected at center-of-mass energies of 7 and 8 TeV by LHCb. The inclusive top quark production cross sections in the fiducial region are σ(top)[7  TeV] = 239 ± 53(stat) ± 33(syst) ± 24(theory)  fb, σ(top)[8  TeV] = 289 ± 43(stat) ± 40(syst) ± 29(theory)  fb.These results, along with the observed differential yields and c…

Top quarkParticle physicsPhysics MultidisciplinaryGeneral Physics and AstronomyFOS: Physical sciences7. Clean energy01 natural sciencesJets in large-Q2 scatteringSettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - ExperimentStandard ModelNONuclear physicsPhysics and Astronomy (all)High Energy Physics - Experiment (hep-ex)0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]RapiditySDG 7 - Affordable and Clean Energy010306 general physicsNuclear ExperimentPhysicslhcbMuon/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyScience & Technology010308 nuclear & particles physicsPhysicsSettore FIS/01 - Fisica SperimentaleParticle physicsSigmaCharge (physics)Top quarkHEP14.70.FmPseudorapidity13.87.-aPhysical SciencesW boson14.65.HaProduction (computer science)High Energy Physics::ExperimentLHCFísica de partículesExperimentsDECAYParticle Physics - Experiment
researchProduct

Study of W Boson Production in Association with Beauty and Charm

2015

The associated production of a W boson with a jet originating from either a light parton or heavy-flavor quark is studied in the forward region using proton-proton collisions. The analysis uses data corresponding to integrated luminosities of 1.0 and 2.0  fb[superscript -1] collected with the LHCb detector at center-of-mass energies of 7 and 8 TeV, respectively. The W bosons are reconstructed using the W → μν decay and muons with a transverse momentum, p[subscript T], larger than 20 GeV in the pseudorapidity range 2.0 20  GeV and 2.2 20  GeV. The fraction of W + jet events that originate from beauty and charm quarks is measured, along with the charge asymmetries of the W + b and W + c produ…

PartonATLAS DETECTOR01 natural sciencesPRODUCTION CROSS-SECTIONSHigh Energy Physics - ExperimentPhysics Particles & FieldsSettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - Experiment (hep-ex)[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Charm (quantum number)Nuclear ExperimentBosonPhysicsPhysicsParticle physics14.70.FmPseudorapidityPhysical Sciences13.87.-aLHCParticle Physics - ExperimentQuarkNuclear and High Energy PhysicsParticle physicsCOLLISIONSAstrophysics::High Energy Astrophysical PhenomenaFOS: Physical sciencesLHCb - Abteilung HofmannHadronsAstronomy & AstrophysicsCharm quarkStandard ModelNOJets in large-Q2 scatteringNuclear physicsRATIO0103 physical sciencesSDG 7 - Affordable and Clean Energy010306 general physicsLarge Hadron Collider (France and Switzerland)MuonScience & Technology/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyROOT-S=7 TEV010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyGran Col·lisionador d'HadronsHEPLHCbJETSW bosonHigh Energy Physics::ExperimentFísica de partículesExperimentsDECAY
researchProduct

First study of the CP-violating phase and decay-width difference in Bs0→ψ(2S)ϕ decays

2016

A time-dependent angular analysis of Bs0→ψ(2S)ϕ decays is performed using data recorded by the LHCb experiment. The data set corresponds to an integrated luminosity of 3.0fb−1 collected during Run 1 of the LHC. The CP-violating phase and decay-width difference of the Bs0 system are measured to be ϕs=0.23−0.28+0.29±0.02rad and ΔΓs=0.066−0.044+0.041±0.007ps−1, respectively, where the first uncertainty is statistical and the second systematic. This is the first time that ϕs and ΔΓs have been measured in a decay containing the ψ(2S) resonance.

PhysicsNuclear and High Energy PhysicsParticle physicsLarge Hadron ColliderLuminosity (scattering theory)010308 nuclear & particles physicsPhase (waves)Astrophysics01 natural sciencesResonance (particle physics)Angular distribution0103 physical sciencesCP violation010306 general physicsPhysics Letters B
researchProduct

Measurement of CP asymmetry in Bs0 → Ds ∓K± decays

2014

Journal of high energy physics 2018(3), 59 (2018). doi:10.1007/JHEP03(2018)059

B physicCKM angle gamma01 natural sciencesB physicsLuminosityFlavor physicsHadron-Hadron scattering (experiments)TOOLLHCb - Abteilung HintonQCmedia_commonPhysicsParticle physicsCharge conjugation parity time reversal and other discrete symmetrie12.15.HhB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron ScatteringJustice and Strong InstitutionsCP violationB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron Scattering; Nuclear and High Energy PhysicsFísica nuclearLHCAstrophysics::Earth and Planetary AstrophysicsParticle physicsNuclear and High Energy PhysicsVIOLATIONSDG 16 - PeaceVIOLATION; GAMMA; TOOLAstrophysics::High Energy Astrophysical Phenomenamedia_common.quotation_subject14.40.NdLHCb - Abteilung HofmannAstrophysics::Cosmology and Extragalactic AstrophysicsHadrons530Determination of Cabibbo-Kobayashi & Maskawa (CKM) matrix elementAsymmetryNOHadronic decays of bottom mesonTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY0103 physical scienceslcsh:Nuclear and particle physics. Atomic energy. Radioactivityddc:530010306 general physicsLarge Hadron Collider (France and Switzerland)Astrophysics::Galaxy AstrophysicsHadron-Hadron Scattering010308 nuclear & particles physicsSDG 16 - Peace Justice and Strong InstitutionsGran Col·lisionador d'HadronsGAMMA/dk/atira/pure/sustainabledevelopmentgoals/peace_justice_and_strong_institutionsHEPLHCbFlavor physic13.25.HwB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron scattering (experiments)lcsh:QC770-798Bottom mesons (|B|>0)11.30.ErHigh Energy Physics::ExperimentB physics CKM angle gamma CP violation Flavor physics Hadron-Hadron ScatteringFísica de partículesExperiments
researchProduct

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

2021

Abstract Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in su…

MaleCOVID-19 Vaccinesafe surgery; vaccination modelling; COVID-19Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]MULTICENTERComorbidity030230 surgery0302 clinical medicinephase 3 clinical trial (topic)Case fatality rateProspective StudiesSARS-CoV-2 Vaccination Safe surgeryCOVID-19/epidemiologySARS-CoV-2 ; vaccination ; safe surgeryeducation.field_of_studycase fatality rateVaccinationVaccinationAdolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Period; Prospective Studies; SARS-CoV-2; Vaccination; Young Adulthealth care policyElective Surgical Procedures030220 oncology & carcinogenesisvaccination modellingPreoperative PeriodCOVID-19; SARS-CoV-2; cancer; vaccination; outcome; mortality; infection; modellingCohort studyprospective studyHumanmedicine.medical_specialtyArticle03 medical and health sciencesSARS-CoV-2 vaccinationSDG 3 - Good Health and Well-beingCOVID-19 Vaccines/pharmacologyHumansVaccination/methodsElective surgeryeducationAgedScience & TechnologyElective Surgical Procedureadult; aged; Article; cancer grading; cancer surgery; case fatality rate; computer assisted tomography; elective surgery; female; follow up; health care policy; human; incidence; infection rate; infection risk; major clinical study; male; middle aged; mortality; outcome assessment; phase 3 clinical trial (topic); preoperative care; prospective study; sensitivity analysis; seroprevalence; Severe acute respiratory syndrome coronavirus 2; vaccination; young adult; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Postoperative Complications; Preoperative Period; SARS-CoV-2; Vaccination; surgery.Cura preoperatòriamajor clinical studymortalityinfectionProspective StudieincidenceSurgeryHuman medicinePostoperative Complication610 Medizin und GesundheitAcademicSubjects/MED00910Settore MED/18 - CHIRURGIA GENERALESettore MED/29 - CHIRURGIA MAXILLOFACCIALEcomputer assisted tomographyESTUDOS PROSPECTIVOSsurgerysafe surgeryPostoperative Complicationssensitivity analysisSevere acute respiratory syndrome coronavirus 2preoperative careVacunacióProspective cohort studyseroprevalenceIncidence (epidemiology)covidElective Surgical Procedures/methodsMiddle Agedcancer gradingCOVID vaccinationoutcome/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSARS-CoV-2; vaccination; surgeryOriginal ArticleFemalecancer surgeryAcademicSubjects/MED00010Life Sciences & BiomedicineAdultCOVID-19 VaccinesAdolescentinternational prospective cohort studyPostoperative Complications/prevention & controlPopulationinfection rateSARS-CoV-2/immunologyNOmodellingYoung Adultmedicinefollow upcancerddc:610infection riskoutcome assessmentLS7_4business.industrySARS-CoV-2Number needed to vaccinatePreoperative careCOVID-193126 Surgery anesthesiology intensive care radiologySettore MED/18Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]elective surgeryEmergency medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe British Journal of Surgery
researchProduct

Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy

2015

This Report intends to estimate the total number of people still alive in 2010 after cancer diagnosis in Italy, regardless of the time since diagnosis, and to project these estimates to 2015. This study is also aimed to estimate the number of already cured cancer patients, whose mortality rates have become undistinguishable from that of the general population of the same age and sex.The study took advantage of the information from the AIRTUM database, which included 29 Cancer Registries (covering 21 million people, 35% of the Italian population). A total of 1,624,533 cancer cases diagnosed between 1976 and 2009 contributed to the study. For each registry, the observed prevalence was calcula…

Aged 80 and overMaleMedicine (all)Aged; Aged 80 and over; Female; Humans; Italy; Male; Middle Aged; Neoplasms; Prevalence; Registries; Survival RateSocio-culturaleMiddle AgedSettore MED/42 - Igiene Generale E ApplicataSurvival RateItalyNeoplasms80 and overPrevalenceHumanscancer prevalence cancer incidence cancer in ItalyFemaleRegistriesAged
researchProduct